Evidence map›Paper›PMID 33163344›Full record

ArticleActa pharmaceutica Sinica. B2020

Interacting with

Etta Y L Liu, Yingjie Xia, Xiangpeng Kong, Maggie S S Guo, Anna X D Yu, Brody Z Y Zheng, Shinghung Mak, Miranda L Xu, Karl W K Tsim

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Experimental neurobiology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Cholinergic Polarization of Human Macrophages.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ.Journal of inflammation (London, England) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Etta Y L LiuKey Laboratory of Food Quality and Safety of Guangdong Province, College of Food Science, South China Agricultural University, Guangzhou 510642, China.
Yingjie XiaShenzhen Key Laboratory of Edible and Medicinal Bioresources, the Hong Kong University of Science and Technology, Shenzhen 518057, China.
Xiangpeng KongShenzhen Key Laboratory of Edible and Medicinal Bioresources, the Hong Kong University of Science and Technology, Shenzhen 518057, China.
Maggie S S GuoShenzhen Key Laboratory of Edible and Medicinal Bioresources, the Hong Kong University of Science and Technology, Shenzhen 518057, China.
Anna X D YuShenzhen Key Laboratory of Edible and Medicinal Bioresources, the Hong Kong University of Science and Technology, Shenzhen 518057, China.
Brody Z Y ZhengShenzhen Key Laboratory of Edible and Medicinal Bioresources, the Hong Kong University of Science and Technology, Shenzhen 518057, China.
Shinghung MakShenzhen Key Laboratory of Edible and Medicinal Bioresources, the Hong Kong University of Science and Technology, Shenzhen 518057, China.
Miranda L XuShenzhen Key Laboratory of Edible and Medicinal Bioresources, the Hong Kong University of Science and Technology, Shenzhen 518057, China.
Karl W K TsimShenzhen Key Laboratory of Edible and Medicinal Bioresources, the Hong Kong University of Science and Technology, Shenzhen 518057, China.
Hong Kong University of Science and Technology · HKSouth China Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetylcholine (ACh) regulates inflammation

Indexed as

ACh, acetylcholineAChEAChE, acetylcholinesteraseBChE, butyrylcholinesteraseCAP pathway, cholinergic anti-inflammatory pathwayCDC42, cell division cycleChAT, choline acetyltransferaseCholinergic anti-inflammatory pathwayDPZ, donepezilGAL, galantamine hydrobromideIL, interleukinLPS, lipopolysaccharidesMacrophageMLA, methyllycaconitine citrate saltMMP, matrix metalloproteinasenAChR, nicotinic AChRNF-κB, nuclear factor-κBPHA, PHA-543613PRiMA, proline-rich membrane anchorTNF-α, tumor necrosis factor αα7 nAChR

Identifiers

PMID33163344
PMCPMC7606108
OpenAlexW3028602370

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.